- Home
- GALT vs ECF Comparison
GALT vs ECF Comparison
Compare GALT & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- ECF
- Stock Information
- Founded
- GALT 2000
- ECF 1986
- Country
- GALT United States
- ECF United States
- Employees
- GALT N/A
- ECF N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- ECF Finance/Investors Services
- Sector
- GALT Health Care
- ECF Finance
- Exchange
- GALT Nasdaq
- ECF Nasdaq
- Market Cap
- GALT 147.8M
- ECF 136.5M
- IPO Year
- GALT N/A
- ECF N/A
- Fundamental
- Price
- GALT $1.04
- ECF $9.58
- Analyst Decision
- GALT Strong Buy
- ECF
- Analyst Count
- GALT 1
- ECF 0
- Target Price
- GALT $11.00
- ECF N/A
- AVG Volume (30 Days)
- GALT 1.1M
- ECF 57.7K
- Earning Date
- GALT 11-13-2024
- ECF 01-01-0001
- Dividend Yield
- GALT N/A
- ECF 6.42%
- EPS Growth
- GALT N/A
- ECF N/A
- EPS
- GALT N/A
- ECF 0.46
- Revenue
- GALT N/A
- ECF N/A
- Revenue This Year
- GALT N/A
- ECF N/A
- Revenue Next Year
- GALT N/A
- ECF N/A
- P/E Ratio
- GALT N/A
- ECF $17.61
- Revenue Growth
- GALT N/A
- ECF N/A
- 52 Week Low
- GALT $0.73
- ECF $7.02
- 52 Week High
- GALT $4.27
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- ECF 42.15
- Support Level
- GALT $1.80
- ECF $9.48
- Resistance Level
- GALT $2.36
- ECF $9.93
- Average True Range (ATR)
- GALT 0.27
- ECF 0.10
- MACD
- GALT -0.08
- ECF -0.06
- Stochastic Oscillator
- GALT 15.07
- ECF 18.18
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.